Preclinical Bioavailability, Tissue Distribution, and Protein Binding Studies of Erinacine A, a Bioactive Compound from <i>Hericium erinaceus</i> Mycelia Using Validated LC-MS/MS Method

Preclinical Bioavailability, Tissue Distribution, and Protein Binding Studies of Erinacine A, a Bioactive Compound from <i>Hericium erinaceus</i> Mycelia Using Validated LC-MS/MS Method

Erinacine A, derived from the mycelia of <i>Hericium erinaceus</i>, has attracted much attention due to its neuroprotective properties. However, very few studies have been conducted on the bioavailability, tissue distribution, and protein binding of erinacine A. This study aimed to inves...

Full description

Bibliographic Details
Main Authors: Pei-Ching Tsai, Yi-Kai Wu, Jun-Hao Hu, I-Chen Li, Ting-Wei Lin, Chin-Chu Chen, Chia-Feng Kuo
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Molecules
Subjects:
<i>Hericium erinaceus</i> mycelia
erinacine A
bioavailability
tissue distribution
excretion
Online Access:https://www.mdpi.com/1420-3049/26/15/4510

Internet

https://www.mdpi.com/1420-3049/26/15/4510

Similar Items